These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

156 related items for PubMed ID: 21893273

  • 21. [Non-alcoholic steatohepatitis].
    Alvarez-Martínez H, Pérez-Campos E.
    Rev Gastroenterol Mex; 2002; 67(2):118-25. PubMed ID: 12214335
    [Abstract] [Full Text] [Related]

  • 22. Nonalcoholic fatty liver disease: hepatic manifestation of obesity and the metabolic syndrome.
    Boppidi H, Daram SR.
    Postgrad Med; 2008 Jul 31; 120(2):E01-7. PubMed ID: 18654060
    [Abstract] [Full Text] [Related]

  • 23. The impact of bariatric surgery on nonalcoholic steatohepatitis.
    Rabl C, Campos GM.
    Semin Liver Dis; 2012 Feb 31; 32(1):80-91. PubMed ID: 22418890
    [Abstract] [Full Text] [Related]

  • 24. Therapy of NAFLD: antioxidants and cytoprotective agents.
    Chang CY, Argo CK, Al-Osaimi AM, Caldwell SH.
    J Clin Gastroenterol; 2006 Mar 31; 40 Suppl 1():S51-60. PubMed ID: 16540769
    [Abstract] [Full Text] [Related]

  • 25. Effects of weight loss on nonalcoholic fatty liver disease.
    Rafiq N, Younossi ZM.
    Semin Liver Dis; 2008 Nov 31; 28(4):427-33. PubMed ID: 18956298
    [Abstract] [Full Text] [Related]

  • 26. Non-alcoholic fatty liver disease from pathogenesis to management: an update.
    Musso G, Gambino R, Cassader M.
    Obes Rev; 2010 Jun 31; 11(6):430-45. PubMed ID: 19845871
    [Abstract] [Full Text] [Related]

  • 27. Current treatment of non-alcoholic fatty liver disease.
    Ahmed MH, Byrne CD.
    Diabetes Obes Metab; 2009 Mar 31; 11(3):188-95. PubMed ID: 18564173
    [Abstract] [Full Text] [Related]

  • 28. Therapeutic strategies in nonalcoholic fatty liver disorders.
    Poordad FF.
    Expert Opin Emerg Drugs; 2005 May 31; 10(2):237-9. PubMed ID: 15934865
    [Abstract] [Full Text] [Related]

  • 29. The metabolic syndrome and nonalcoholic fatty liver disease.
    Collantes RS, Ong JP, Younossi ZM.
    Panminerva Med; 2006 Mar 31; 48(1):41-8. PubMed ID: 16633331
    [Abstract] [Full Text] [Related]

  • 30. Non-alcoholic fatty liver disease.
    Smith BW, Adams LA.
    Crit Rev Clin Lab Sci; 2011 Mar 31; 48(3):97-113. PubMed ID: 21875310
    [Abstract] [Full Text] [Related]

  • 31. Nonalcoholic fatty liver disease of obesity.
    Sachdev MS, Riely CA, Madan AK.
    Obes Surg; 2006 Nov 31; 16(11):1412-9. PubMed ID: 17132404
    [Abstract] [Full Text] [Related]

  • 32. Current status of liver disease in Korea: nonalcoholic fatty liver disease.
    Park SH.
    Korean J Hepatol; 2009 Dec 31; 15 Suppl 6():S34-9. PubMed ID: 20037278
    [Abstract] [Full Text] [Related]

  • 33. Review article: current management of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis.
    Younossi ZM.
    Aliment Pharmacol Ther; 2008 Jul 31; 28(1):2-12. PubMed ID: 18410557
    [Abstract] [Full Text] [Related]

  • 34. Non-alcoholic steatohepatitis in children.
    Nanda K.
    Pediatr Transplant; 2004 Dec 31; 8(6):613-8. PubMed ID: 15598336
    [Abstract] [Full Text] [Related]

  • 35. [Liver disease in obese patients].
    Giostra E, Huber O, Morel P, Hadengue A.
    Rev Med Suisse; 2007 Sep 05; 3(123):1939-41. PubMed ID: 17918488
    [Abstract] [Full Text] [Related]

  • 36. Pediatric nonalcoholic fatty liver disease.
    Lerret SM, Skelton JA.
    Gastroenterol Nurs; 2008 Sep 05; 31(2):115-9. PubMed ID: 18391799
    [Abstract] [Full Text] [Related]

  • 37. Thiazolidinediones and the liver in humans.
    Yki-Järvinen H.
    Curr Opin Lipidol; 2009 Dec 05; 20(6):477-83. PubMed ID: 19779336
    [Abstract] [Full Text] [Related]

  • 38. Combined treatment with ursodeoxycholic acid and pioglitazone in a patient with NASH associated with type 2 diabetes and psoriasis.
    Itoh S, Kanazuka A, Akimoto T.
    Dig Dis Sci; 2003 Nov 05; 48(11):2182-6. PubMed ID: 14705825
    [No Abstract] [Full Text] [Related]

  • 39. Treatment strategies in nonalcoholic fatty liver disease.
    Tilg H, Kaser A.
    Nat Clin Pract Gastroenterol Hepatol; 2005 Mar 05; 2(3):148-55. PubMed ID: 16265156
    [Abstract] [Full Text] [Related]

  • 40. [Can metabolic steatohepatitis be treated?].
    Ratziu V, Vispo M, Tahiri M, Bonyhay L, de Torres M, Bernhardt C, Poynard T, Lebray P.
    Gastroenterol Clin Biol; 2007 Mar 05; 31(3):333-40. PubMed ID: 17396098
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.